Article Details

CTI BioPharma (CTIC) Receives a Buy from Needham

Retrieved on: 2021-03-18 09:33:45

Tags for this article:

Click the tags to see associated articles and topics

CTI BioPharma (CTIC) Receives a Buy from Needham. View article details on hiswai:

Excerpt

In a report released today, Chad Messer from Needham reiterated a Buy rating on CTI BioPharma (CTIC), with a price target of $6.00. The company's ...

Article found on: www.smarteranalyst.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo